Thomson Medical Group

Thomson Medical to expand IVF services to China

SINGAPORE (Aug 14): Healthcare operator Thomson Medical Group plans to establish in-vitro fertilisation (IVF) centres in China and other Southeast Asian markets, in collaboration with assisted reproduction specialist IVI-RMA.

Thomson Medical enters assisted reproduction JV with IVI-RMA Global

SINGAPORE (July 27): Thomson Medical Group (TMG) has partnered IVI RMA Global, a medical group specialising in assisted reproductive technologies (ART), to set up a Singapore-headquartered ART platform to serve the region.

Results

Thomson Medical's 1Q losses widen to $6.52 mil

SINGAPORE (May 14): Thomson Medical, formerly known as Rowsley, says first quarter losses widened to $6.5 million in 1Q18 from $1.55 million in 1Q17.

Rowsley renames to Thomson Medical Group as shareholders approve healthcare acquisitions

SINGAPORE (Mar 24): The shareholders of Rowsley have voted in favour of the proposed healthcare acquisition from controlling shareholder Peter Lim Eng Hock.

M&A

Rowsley says sale price of TMC Life Sciences warrants set at $34.8 mil

SINGAPORE (Mar 19): Rowsley says the cash consideration for the warrants of TMC Life Sciences (TMCLS) is set at RM103.75 million ($34.8 million).

Rowsley unveils plan to more than treble number of hospital beds by 2021

SINGAPORE (Mar 14): Real estate company Rowsley has unveiled plans to capitalise on the increasing demand for healthcare services in the region, ahead of an extraordinary general meeting (EGM) scheduled for Mar 23.

In print this week

Is Rowsley attractive now that price of Thomson Medical has been lowered?

SINGAPORE (Jan 8): Rowsley’s announcement in July last year that it would morph into a healthcare company has kept its stock trading heavily — and at rather rich valuations — for several months.

M&A

Rowsley shares jump 23% on announcement of healthcare assets acquisition

SINGAPORE (Dec 18): Shares of Rowsley jumped 22.5%, or 2.5 cents, to close at 13.6 cents on Monday after the real estate and investment firm announced it is acquiring $1.6 billion worth of healthcare assets from controlling shareholder Peter Lim Eng Hock.
  •  
×